144 related articles for article (PubMed ID: 24686986)
1. Human chorionic gonadotropin and indolamine 2,3-dioxygenase in patients with GVHD.
Elmaagacli AH; Ditschkowski M; Steckel NK; Gromke T; Ottinger H; Hillen U; Baba HA; Trenschel R; Beelen DW; Koldehoff M
Bone Marrow Transplant; 2014 Jun; 49(6):800-5. PubMed ID: 24686986
[TBL] [Abstract][Full Text] [Related]
2. Urinary-derived human chorionic gonadotropin to induce tolerance and promote healing in steroid-refractory GvHD.
Holtan SG; Panoskaltsis-Mortari A
Bone Marrow Transplant; 2016 Jan; 51(1):142-3. PubMed ID: 26389834
[No Abstract] [Full Text] [Related]
3. Interleukin-2 and regulatory T cells in graft-versus-host disease.
Koreth J; Matsuoka K; Kim HT; McDonough SM; Bindra B; Alyea EP; Armand P; Cutler C; Ho VT; Treister NS; Bienfang DC; Prasad S; Tzachanis D; Joyce RM; Avigan DE; Antin JH; Ritz J; Soiffer RJ
N Engl J Med; 2011 Dec; 365(22):2055-66. PubMed ID: 22129252
[TBL] [Abstract][Full Text] [Related]
4. A paradoxical pattern of indoleamine 2,3-dioxygenase expression in the colon tissues of patients with acute graft-versus-host disease.
Park G; Choi YJ; Lee SE; Lim JY; Lee C; Choi EY; Min CK
Exp Hematol; 2014 Sep; 42(9):734-40. PubMed ID: 24732701
[TBL] [Abstract][Full Text] [Related]
5. Increased plasma indoleamine 2,3-dioxygenase activity and interferon-γ levels correlate with the severity of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Xu J; Wei J; Zhu X; Zhang X; Guan J; Wang J; Yin J; Xiao Y; Zhang Y
Biol Blood Marrow Transplant; 2013 Feb; 19(2):196-201. PubMed ID: 23089565
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
[TBL] [Abstract][Full Text] [Related]
7. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
Front Immunol; 2018; 9():3104. PubMed ID: 30733722
[TBL] [Abstract][Full Text] [Related]
8. IDO in human gut graft-versus-host disease.
Ratajczak P; Janin A; Peffault de Larour R; Koch L; Roche B; Munn D; Blazar BR; Socié G
Biol Blood Marrow Transplant; 2012 Jan; 18(1):150-5. PubMed ID: 21835147
[TBL] [Abstract][Full Text] [Related]
9. Tryptophan catabolism is associated with acute GVHD after human allogeneic stem cell transplantation and indicates activation of indoleamine 2,3-dioxygenase.
Landfried K; Zhu W; Waldhier MC; Schulz U; Ammer J; Holler B; Wolff D; Edinger M; Peter K; Kreutz M; Andreesen R; Oefner PJ; Holler E
Blood; 2011 Dec; 118(26):6971-4. PubMed ID: 22039265
[TBL] [Abstract][Full Text] [Related]
10. Transient upregulation of indoleamine 2,3-dioxygenase in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes.
Ueno A; Cho S; Cheng L; Wang J; Hou S; Nakano H; Santamaria P; Yang Y
Diabetes; 2007 Jun; 56(6):1686-93. PubMed ID: 17360980
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of pDCs, mDCs, γδT cells and regulatory T cells in association with graft versus host disease after hematopoietic stem cell transplantation.
Watanabe N; Narita M; Furukawa T; Nakamura T; Yamahira A; Masuko M; Toba K; Fuse I; Aizawa Y; Takahashi M
Int J Lab Hematol; 2011 Aug; 33(4):378-90. PubMed ID: 21692996
[TBL] [Abstract][Full Text] [Related]
13. The initial phase of graft-versus-host disease is associated with a decrease of CD4+CD25+ regulatory T cells in the peripheral blood of patients after allogeneic stem cell transplantation.
Schneider M; Munder M; Karakhanova S; Ho AD; Goerner M
Clin Lab Haematol; 2006 Dec; 28(6):382-90. PubMed ID: 17105491
[TBL] [Abstract][Full Text] [Related]
14. Potential immunosuppressive function of plasma indoleamine 2,3-dioxygenase in patients with aGVHD after allo-HSCT.
Zhao XS; Liu KY; Liu DH; Xu LP; Chen H; Huang XJ
Clin Transplant; 2011; 25(3):E304-11. PubMed ID: 21355883
[TBL] [Abstract][Full Text] [Related]
15. Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse.
Bremm M; Huenecke S; Lehrnbecher T; Ponstingl E; Mueller R; Heinze A; Bug G; Quaiser A; Kapinsky M; Brehm C; Bader P; Schneider G; Klingebiel T; Koehl U
J Immunol Methods; 2011 Oct; 373(1-2):36-44. PubMed ID: 21839739
[TBL] [Abstract][Full Text] [Related]
16. Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality.
Jasperson LK; Bucher C; Panoskaltsis-Mortari A; Mellor AL; Munn DH; Blazar BR
Blood; 2009 Dec; 114(24):5062-70. PubMed ID: 19828695
[TBL] [Abstract][Full Text] [Related]
17. Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4(+)CD25 (high)CD127 (low/-) regulatory T cells.
Ukena SN; Grosse J; Mischak-Weissinger E; Buchholz S; Stadler M; Ganser A; Franzke A
Ann Hematol; 2011 Feb; 90(2):213-8. PubMed ID: 20859740
[TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2, 3-Dioxgenase Transfected Mesenchymal Stem Cells Induce Kidney Allograft Tolerance by Increasing the Production and Function of Regulatory T Cells.
He Y; Zhou S; Liu H; Shen B; Zhao H; Peng K; Wu X
Transplantation; 2015 Sep; 99(9):1829-38. PubMed ID: 26308414
[TBL] [Abstract][Full Text] [Related]
19. IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity.
Lu Y; Giver CR; Sharma A; Li JM; Darlak KA; Owens LM; Roback JD; Galipeau J; Waller EK
Blood; 2012 Jan; 119(4):1075-85. PubMed ID: 22130799
[TBL] [Abstract][Full Text] [Related]
20. Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity.
Kennedy-Nasser AA; Ku S; Castillo-Caro P; Hazrat Y; Wu MF; Liu H; Melenhorst J; Barrett AJ; Ito S; Foster A; Savoldo B; Yvon E; Carrum G; Ramos CA; Krance RA; Leung K; Heslop HE; Brenner MK; Bollard CM
Clin Cancer Res; 2014 Apr; 20(8):2215-25. PubMed ID: 24573552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
